BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3528220)

  • 1. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.
    Arnolda L; McGrath BP; Cocks M; Johnston CI
    J Clin Invest; 1986 Sep; 78(3):674-9. PubMed ID: 3528220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vasopressin in experimental congestive cardiac failure.
    Johnston CI; Arnolda L; Abrahams J; McGrath B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S96-100. PubMed ID: 2434782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
    Arnolda L; McGrath BP; Johnston CI
    Cardiovasc Res; 1991 Jan; 25(1):68-72. PubMed ID: 2054832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic adriamycin treatment and its effect on the cardiac beta-adrenergic system in the rabbit.
    Bocherens-Gadient SA; Quast U; Nussberger J; Brunner HR; Hof RP
    J Cardiovasc Pharmacol; 1992 May; 19(5):770-8. PubMed ID: 1381776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular actions of atrial natriuretic factor in sheep with cardiac failure.
    Parkes DG; Coghlan JP; Cooper EA; Routley M; McDougall JG; Scoggins BA
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):905-12. PubMed ID: 7826554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peripheral distribution of cardiac output in heart failure.
    Zelis R; Sinoway L; Musch T; Davis D
    Z Kardiol; 1988; 77 Suppl 5():61-5. PubMed ID: 3066042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vasopressin in cardiovascular adaptation to sodium depletion in the conscious rat.
    McGrath BP; Jover B; Dupont M; Mimran A
    J Hypertens Suppl; 1985 Dec; 3(3):S439-42. PubMed ID: 2856760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist.
    Höhne C; Francis RC; Kaczmarczyk G; Boemke W
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():336S-339S. PubMed ID: 12193117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to graded treadmill exercise during the development of doxorubicin induced heart failure in rabbits.
    Langton D; Jover B; McGrath BP; Ludbrook J
    Cardiovasc Res; 1990 Dec; 24(12):959-68. PubMed ID: 2097062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.
    Waeber B; Nussberger J; Brunner HR
    J Pharmacol Exp Ther; 1983 May; 225(2):442-6. PubMed ID: 6341543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.